Ben Dake (Source: Aerovate)
RA Capital-backed Aerovate launches with $72.6M to treat PAH with a repurposed cancer med
The landmark cancer drug imatinib has been on the market since 2001, first sold by Novartis as Gleevec and in recent years as a generic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
